Central Admixture Pharmacy Services recalls
8 official recalls and safety alerts involving Central Admixture Pharmacy Services since 2023-05, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.
This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with Central Admixture Pharmacy Services or the relevant agency.
- 2026-08-12
US
- 2026-07-01
US
Central Admixture Pharmacy Services, Inc. recalls Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Rx# 24-1269856-0-1Compound…
Incorrect product formulation: bag did not contain copper and famotidine per label.
- 2025-03-19
US
Central Admixture Pharmacy Services, Inc. recalls PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), Rx Only, CAPS, Central Admixture Pharmacy…
Presence of Particulate Matter
FDA · DrugCentral Admixture Pharmacy Services, Inc.Product was distributed nationwide within the United StatesOfficial notice →- 2023-10-11
US
- 2023-09-06
US
Central Admixture Pharmacy Services, Inc. recalls EPINEPHrine added to dextrose 5%, 4mg/250ml (16 mcg/mL), IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc.,…
Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
- 2023-08-09
US
Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% sodium chloride, 15 mg/30 mL, (0.5 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy…
Lack of assurance of sterility: Lack of validation data for sanitization cycles
US
Central Admixture Pharmacy Services, Inc. recalls Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 5% with CALCIUM, total volume = 250mL, IV Bag, Rx Only,…
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
- 2023-05-31
US
Central Admixture Pharmacy Services, Inc. recalls vasopressin 20 units added to 0.9% sodium chloride 100 mL*, 0.2 units/mL*, 100 mL per bag, Rx only, Central Admixture…
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.